- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 20 residues within 4Å:- Chain A: K.80, G.215, G.216, G.217, Y.218, I.219, E.222, Y.241, R.242, R.248, N.274, A.304, I.305, G.306, R.307, M.353, L.354, A.385, F.387
- Ligands: FAD.1
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:Y.218, A:I.219
- Hydrogen bonds: A:K.80, A:G.216, A:G.216, A:Y.218, A:I.219, A:Y.241, A:R.242, A:N.274, A:R.307, A:A.385
- Salt bridges: A:R.242, A:R.248
- pi-Stacking: A:Y.218
- pi-Cation interactions: A:R.242, A:R.242
NDP.4: 19 residues within 4Å:- Chain B: K.80, G.216, G.217, Y.218, I.219, E.222, Y.241, R.242, R.248, N.274, A.304, I.305, G.306, R.307, M.353, L.354, A.385, F.387
- Ligands: FAD.3
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:Y.218, B:I.219
- Hydrogen bonds: B:K.80, B:G.216, B:G.216, B:Y.218, B:I.219, B:Y.241, B:R.242, B:A.304, B:G.306, B:A.385
- Salt bridges: B:R.242, B:R.248
- pi-Stacking: B:Y.218
- pi-Cation interactions: B:R.242, B:R.242
- 4 x JV0: 4-[[1-(4-ethylphenyl)-2-methyl-5-(4-methylsulfanylphenyl)pyrrol-3-yl]methyl]thiomorpholine(Non-covalent)
JV0.5: 8 residues within 4Å:- Chain A: S.34, L.37, E.38, Y.130
- Chain B: S.415, F.416, E.487
- Ligands: JV0.8
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:E.487
JV0.6: 10 residues within 4Å:- Chain A: S.414, S.415, F.416, E.487
- Chain B: S.34, L.37, E.38, W.41, Y.130
- Ligands: JV0.7
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.41
- Salt bridges: A:E.487
JV0.7: 9 residues within 4Å:- Chain A: F.416, T.417, L.419, H.481
- Chain B: V.73, S.129, Y.130, M.133
- Ligands: JV0.6
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:Y.130, B:M.133
JV0.8: 7 residues within 4Å:- Chain A: V.73, V.78, S.129, Y.130, M.133
- Chain B: L.419
- Ligands: JV0.5
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:Y.130, A:M.133, B:L.419
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baiocco, P. et al., Inhibition of Leishmania Infantum Trypanothione Reductase by Azole-Based Compounds: A Comparative Analysis with its Physiological Substrate by X-Ray Crystallography. Chemmedchem (2013)
- Release Date
- 2013-04-17
- Peptides
- TRYPANOTHIONE REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x JV0: 4-[[1-(4-ethylphenyl)-2-methyl-5-(4-methylsulfanylphenyl)pyrrol-3-yl]methyl]thiomorpholine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baiocco, P. et al., Inhibition of Leishmania Infantum Trypanothione Reductase by Azole-Based Compounds: A Comparative Analysis with its Physiological Substrate by X-Ray Crystallography. Chemmedchem (2013)
- Release Date
- 2013-04-17
- Peptides
- TRYPANOTHIONE REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B